The largest database of trusted experimental protocols

Pet 28b expression vector

Manufactured by GenScript
Sourced in United States

The PET-28b expression vector is a plasmid used for the expression of recombinant proteins in Escherichia coli. It features a T7 promoter for high-level protein expression, a kanamycin resistance gene for selection, and a His-tag sequence for protein purification.

Automatically generated - may contain errors

3 protocols using pet 28b expression vector

1

Construction of GgCL and GgCAD Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
For construction of GgCL expression plasmids, the LOC418544 (NCBI GeneID: 418544) CDS sequence (XM_015300896) inserted into pcDNA3.1+/C-(K)DYK vector was purchased from GenScript (USA Inc.). The sequence was then amplified using CBSL_Fw, CBSL_Rev primers (native GgCL) or CBSL_Fw, CBSL_short_Rev (truncated GgCL) by PCR, using Phusion DNA polymerase, and inserted into pET-28b expression vector at NdeI/XhoI sites, generating respectively pET-28b-nativeGgCL and pET-28b-truncatedGgCL. Details of the designed primers are reported in supplementary Table 1. A first transformation of the constructs into E. coli XL1Blue strain by electroporation was performed for plasmid amplification. Plasmids were extracted by alkaline lysis and transformed into E. coli BL21 Codon Plus strain by electroporation. For construction of GgCAD expression plasmids, GgCAD wild-type sequence (NCBI GeneID: 426184) and mutated sequences (Q467V, T470A, Q467V-T470A) inserted into pET-28b expression vector were purchased from GenScript (USA Inc.), generating respectively pET-28b-GgCAD, pET-28b-GgCAD_Q467V, pET-28b-GgCAD_T470A, pET-28b-GgCAD_Q467V-T470A. The constructs were transformed directly into E. coli BL21 Codon Plus by electroporation. The authenticity of all constructs was verified by sequence analysis.
+ Open protocol
+ Expand
2

Construction of GgCL and GgCAD Plasmids

Check if the same lab product or an alternative is used in the 5 most similar protocols
For construction of GgCL expression plasmids, the LOC418544 (NCBI GeneID: 418544) CDS sequence (XM_015300896) inserted into pcDNA3.1+/C-(K)DYK vector was purchased from GenScript (USA Inc.). The sequence was then amplified using CBSL_Fw, CBSL_Rev primers (native GgCL) or CBSL_Fw, CBSL_short_Rev (truncated GgCL) by PCR, using Phusion DNA polymerase, and inserted into pET-28b expression vector at NdeI/XhoI sites, generating respectively pET-28b-nativeGgCL and pET-28b-truncatedGgCL. Details of the designed primers are reported in supplementary Table 1. A first transformation of the constructs into E. coli XL1Blue strain by electroporation was performed for plasmid amplification. Plasmids were extracted by alkaline lysis and transformed into E. coli BL21 Codon Plus strain by electroporation. For construction of GgCAD expression plasmids, GgCAD wild-type sequence (NCBI GeneID: 426184) and mutated sequences (Q467V, T470A, Q467V-T470A) inserted into pET-28b expression vector were purchased from GenScript (USA Inc.), generating respectively pET-28b-GgCAD, pET-28b-GgCAD_Q467V, pET-28b-GgCAD_T470A, pET-28b-GgCAD_Q467V-T470A. The constructs were transformed directly into E. coli BL21 Codon Plus by electroporation. The authenticity of all constructs was verified by sequence analysis.
+ Open protocol
+ Expand
3

Quantifying Anti-KEX1 Antibodies in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 90 amino acid fragment of human-derived KEX1 was cloned into the pET28b(+) expression vector (GenScript) in Escherichia coli BL21(DE3) pLysS (Thermo Fisher Scientific) and used to produce an approximately 11 kDa recombinant protein. Microtitre plates (Immunolon 4HBX; Thermo Fisher Scientific) were coated with 5 µg/mL of purified KEX1 in phosphate-buffered saline (PBS). Heat-inactivated plasma was diluted 1:100 in blocking buffer (PBS with 5% non-fat milk); 50 µL of plasma were plated into KEX1-coated wells, and serial dilutions were made to determine end point titres. Goat antihuman immunoglobulin-conjugated horseradish peroxidase (1:10 000, IgG; Sigma-Aldrich) was used for detection, and plates were developed by standard methods. Plasma samples from this cohort that had an undetectable Pc antibody titre were used as negative controls. The reciprocal end point titre (RET) was calculated as the highest dilution at which the optical density was the same or less than that of the negative control. To determine whether patients with low anti-KEX1 antibody titres had a generalised defect in humoral immunity, tetanus toxoid antibody levels were determined using commercial ELISA kit (MyBioSource).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!